Safety and tolerability of clofazimine as salvage therapy for atypical mycobacterial infection in solid organ transplant recipients

Transplant Infectious Disease

Volumn 17, Issue 1, 2015, Pages 111-118

  Cariello, P F ^a   Kwak, E J ^a   Abdel Massih, R C ^a   Silveira, F P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Clofazimine; MAC; Mycobacteria; NTM; Solid organ transplant

Indexed keywords

AMIKACIN; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSPORIN; ETHAMBUTOL; METHOTREXATE; MOXIFLOXACIN; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; RIFABUTIN; RIFAMPICIN; TACROLIMUS; LEPROSTATIC AGENT;

ABDOMINAL PAIN; ADJUVANT THERAPY; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIAL ARTHRITIS; BACTERIAL CLEARANCE; BLOOD TOXICITY; BONE MARROW TOXICITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CYSTIC FIBROSIS; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; END STAGE LIVER DISEASE; FEMALE; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TOXICITY; LIVER TRANSPLANTATION; LUNG INFECTION; LUNG TRANSPLANTATION; MALE; MESENTERITIS; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; ORGAN TRANSPLANTATION; PANCYTOPENIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; SIDE EFFECT; SKIN DISCOLORATION; TREATMENT DURATION; TREATMENT INDICATION; VISUAL IMPAIRMENT; VOMITING; ADVERSE EFFECTS; CASE REPORT; DRUG EFFECTS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION;

ADULT; AGED; CLOFAZIMINE; FEMALE; HUMANS; LEPROSTATIC AGENTS; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TRANSPLANT RECIPIENTS;

EID: 84923256216     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12340     Document Type: Article

References (13)

1. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175 (4): 367-416.
2. Keating MR, Daly JS; AST Infectious Diseases Community of Practice. Nontuberculous mycobacterial infections in solid organ transplantation. Am J Transplant 2013; 13 (Suppl 4): 77-82.
3. Knoll BM, Kappagoda S, Gill RR, et al. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study. Transpl Infect Dis 2012; 14 (5): 452-460.
4. Cohn DL, Fisher EJ, Peng GT, et al. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis 1999; 29 (1): 125-133.
5. Fournier S, Burguiere AM, Flahault A, Vincent V, Treilhou MP, Eliaszewicz M. Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients. Eur J Clin Microbiol Infect Dis 1999; 18 (1): 16-22.
6. Vaidya P, Mauer R, Rodgers A, Dillon-Parker M, Navarro AE, Farley F. Clofazimine Use in Patients with Mycobacterial Infections under Single Patient Investigational New Drug (SPIND). ID Week; October 20, 2012; San Diego, CA, 2012.
7. van Ingen J, Totten SE, Helstrom NK, Heifets LB, Boeree MJ, Daley CL. In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease. Antimicrob Agents Chemother 2012; 56 (12): 6324-6327.
8. Shen GH, Wu BD, Hu ST, Lin CF, Wu KM, Chen JH. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria. Inter J Antimicrob Agents 2010; 35 (4): 400-404.
9. Novartis Pharma AG. Lamprene(R) [international package leaflet]. Basel, Switzerland: Novartis Pharma AG, 2005. Available at: http://www.lamprene.com/fileadmin/pharmaworld/lamprene/lamprene_packing_insert.pdf (accessed on June 20, 2014).
10. Field SK, Cowie RL. Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine. Chest 2003; 124 (4): 1482-1486.
11. Guditi S, Ram R, Ismal KM, et al. Leprosy in a renal transplant recipient: review of the literature. Transpl Infect Dis 2009; 11 (6): 557-562.
12. Trindade MA, Palermo ML, Pagliari C, et al. Leprosy in transplant recipients: report of a case after liver transplantation and review of the literature. Transpl Infect Dis 2011; 13 (1): 63-69.
13. Parizhskaya M, Youssef NN, Di Lorenzo C, Goyal RK. Clofazimine enteropathy in a pediatric bone marrow transplant recipient. J Pediatr 2001; 138 (4): 574-576.